Thomas Hornsby

Title: Thomas Hornsby: Innovator in Glucocorticoid Receptor Antagonists

Introduction

Thomas Hornsby is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of glucocorticoid receptor antagonists. With a total of three patents to his name, Hornsby is recognized for his innovative approaches to drug formulation.

Latest Patents

Hornsby's latest patents include "Quaternary indazole glucocorticoid receptor antagonists," which provides compounds of Formula I or II. These compounds may be utilized in pharmaceutical formulations for modulating glucocorticoid receptors. Another significant patent is for "Bicyclic indazole glucocorticoid receptor antagonists," which details compounds of various formulas that can also be used in pharmaceutical applications for the same purpose.

Career Highlights

Hornsby is currently associated with Corcept Therapeutics Incorporated, where he continues to advance his research and development efforts. His work focuses on creating effective pharmaceutical solutions that target glucocorticoid receptors, which play a crucial role in various medical conditions.

Collaborations

Some of Hornsby's coworkers include Hazel Joan Hunt and Lorna Duffy. Their collaborative efforts contribute to the innovative environment at Corcept Therapeutics, fostering advancements in pharmaceutical research.

Conclusion

Thomas Hornsby stands out as a key figure in the development of glucocorticoid receptor antagonists, with a strong patent portfolio and a commitment to pharmaceutical innovation. His contributions are paving the way for new therapeutic options in medicine.